Musculoskeletal pain
Conditions
Interventions
Yunnan Baiyao ointment or Yunnan Baiyao ointment combined with conventional treatment group:NA
Sponsors
West China Hospital of Sichuan University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Age >= 18 years, no gender restrictions; 2. Meet the diagnostic criteria for musculoskeletal pain, including osteoarthritis, low back pain (including non-specific low back pain, spondylogenic low back pain), cervical spondylosis, rotator cuff injury, periarthritis of the shoulder, lateral epicondylitis of the humerus (tennis elbow), medial epicondylitis of the humerus (golfer's elbow), and pain after chronic musculoskeletal injury; 3. Persistent or intermittent pain >= 30 days without indication for surgery; 4. Those who voluntarily sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Generalized pain, cancer-related pain, neuropathic pain (such as herpes zoster and postherpetic neuralgia, sugar Uropathic neuropathy, complex regional pain syndrome, postoperative pain syndrome, phantom limb pain, central pain), vascular pain (e.g., erythematous limb pain, acral percussion, arteriosclerotic occlusion, thromboangiitis obliterans, Raynaud's disease, thrombosedium.) Rheumatoid immune diseases (such as rheumatoid arthritis, ankylosing spondylitis, etc.). 2. Previous history of neurological and psychiatric disorders, such as schizophrenia, depression, epilepsy, or acute seizures of epilepsy or Those who have been taking psychotropic drugs for a long time. 3. Combined with malignant tumors, severe primary cardiovascular lesions (with significant clinical symptoms and possible serious complications cardiovascular disease), severe liver and kidney disease or serious diseases that affect their survival. 4. Those with damaged or skin abnormalities (such as rashes, eczema, after surgery, etc.), and those with allergic skin. 5. Those who have a history of allergy to the patch matrix or the test drug, or have an allergic constitution (allergic to more than 2 types of substances). 6. Pregnant, lactating or with a recent birth plan. 7. Those who have participated in other interventional clinical trials in the past 3 months. 8. Have situations that the investigator deems unsuitable for participation in the study, such as motor or working status that may aggravate pain.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| European Five-Dimensional Health Scale;The time and proportion during which the NRS score for pain decreased by 30% within 7 days of medication use;Anxiety and Depression Scale;laboratory inspection;Pain relief rate;adverse event;The change value of the pain NRS score compared to the baseline;The time and proportion during which the NRS score for pain decreased by 50% within 7 days of medication use;Time of pain relief; | — |
Countries
China
Contacts
Public ContactXiao Hong
West China Hospital of Sichuan University
Outcome results
None listed